Emery J Stephans

Founder & CEO

Emery is the Founder and Chief Executive Officer of Enterprise Analysis Corporation (EAC).

Prior to EAC, Emery had a 26 year career at IBM in various research, development, manufacturing, and product management positions. This included 10 years in IBM’s biomedical systems business unit and two years on special assignment at the New York Hospital – Cornell Medical Center on a project to reverse atherosclerosis by means of extracorporeal depletion of circulatory HDL.

Emery chaired the Industrial Liaison Committee of the American Association of Clinical Chemistry (AACC) POCT division and is also a past chair of the NCCLS Subcommittee on Data Management. Emery has also assisted in setting up a standardization effort for middleware data integration. He holds a BS and MS in Physics from the South Dakota School of Mines & Technology.

Emery specializes in corporate strategy development, portfolio and pipeline evaluation, partnerships in life science and clinical medicine, comprehensive assessments of market opportunities to guide company strategies (e.g. bio-repositories, critical biomarkers in emergency medicine, hospital acquired infections, molecular diagnostics, tissue testing, clinical laboratory automation, data management and connectivity in point of care testing, and animal health and nutrition. Since 2012, he has been engaged in large clinical retrospective outcome studies in Sepsis, and multi-drug resistant infectious microbes.

Contact Emery: estephans@eacorp.com